These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26197855)

  • 21. [TSH receptor antibody in hyperthyroid patients due to Graves' disease treated with antithyroid drugs].
    Yamada T
    Nihon Naibunpi Gakkai Zasshi; 1991 Dec; 67(12):1295-308. PubMed ID: 1723696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change of circulating thyroid autoantibody titers in Graves' hyperthyroidism after antithyroid drugs therapy.
    Lin HD; Tai FT; Chen HD; Lee SP; Chang FY; Wang GG; Tang KT; Lee JK
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):86-90. PubMed ID: 1705860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy.
    Laurberg P; Bournaud C; Karmisholt J; Orgiazzi J
    Eur J Endocrinol; 2009 Jan; 160(1):1-8. PubMed ID: 18849306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of Graves' disease after antithyroid drug treatment in Taiwan.
    Wang PW; Liu RT; Tung SC; Chien WY; Lu YC; Chen CH; Kuo MC; Hsieh JR; Wang ST
    J Formos Med Assoc; 1998 Sep; 97(9):619-25. PubMed ID: 9795530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA; Zang S; Kahaly GJ
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
    Masiello E; Veronesi G; Gallo D; Premoli P; Bianconi E; Rosetti S; Cusini C; Sabatino J; Ippolito S; Piantanida E; Tanda ML; Chiovato L; Wiersinga WM; Bartalena L
    J Endocrinol Invest; 2018 Dec; 41(12):1425-1432. PubMed ID: 29946800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B; Hoermann R; Hahn S; Roggenbuck U; Mann K; Janssen OE
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of thyrotropin receptor antibody levels on fetal development in two successive pregnancies in a woman with Graves' disease.
    Bjørgaas MR; Farstad H; Christiansen SC; Blaas HG
    Horm Res Paediatr; 2013; 79(1):39-43. PubMed ID: 23154300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic Risk Model for the Medical Treatment of Graves' Hyperthyroidism according to Treatment Duration.
    Jin M; Kim CA; Jeon MJ; Kim WB; Kim TY; Kim WG
    Endocrinol Metab (Seoul); 2024 Aug; 39(4):579-589. PubMed ID: 38778479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology].
    Eckstein A; Mann K; Kahaly GJ; Grussendorf M; Reiners C; Feldkamp J; Quadbeck B; Bockisch A; Schott M
    Med Klin (Munich); 2009 May; 104(5):343-8. PubMed ID: 19444414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
    Tun NN; Beckett G; Zammitt NN; Strachan MW; Seckl JR; Gibb FW
    Thyroid; 2016 Aug; 26(8):1004-9. PubMed ID: 27266892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
    Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
    Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies to the thyrotropin receptor.
    Rees Smith B; McLachlan SM; Furmaniak J
    Endocr Rev; 1988 Feb; 9(1):106-21. PubMed ID: 3286231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting the Relapse of Hyperthyroidism in Treated Graves' Disease with Orbitopathy by Serial Measurements of TSH-Receptor Autoantibodies.
    Stöhr M; Oeverhaus M; Lytton SD; Horstmann M; Zwanziger D; Möller L; Stark A; Führer-Sakel D; Bechrakis N; Berchner-Pfannschmidt U; Banga JP; Philipp S; Eckstein A
    Horm Metab Res; 2021 Apr; 53(4):235-244. PubMed ID: 33618407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthyroidism. Current treatment guidelines.
    Gittoes NJ; Franklyn JA
    Drugs; 1998 Apr; 55(4):543-53. PubMed ID: 9561343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis evaluation of the impact of thyrotropin receptor antibodies on long term remission after medical therapy of Graves' disease.
    Feldt-Rasmussen U; Schleusener H; Carayon P
    J Clin Endocrinol Metab; 1994 Jan; 78(1):98-102. PubMed ID: 8288723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.